Sufosfamide
- Level
- Commodity
- Parent
- 51112500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51112523This classification denotes an antipsychotic agent with the molecular formula C8H18ClN2O5PS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2208Y59985, chemically known as 3-(2-chloroethyl)-2-(2-mesyloxyethylamino)tetrahydro-2h-1,3,2-oxazaphosphorin-2-oxide but more generally known as sufosfamide, which bears US NIH Compound Identifier 65805. European Medicines Agency schedules Sufosfamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10672MIG. The term SUFOSFAMIDE is an International Non-Proprietary Name. SUFOSFAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule sufosfamide under HS 29349990 and SITC 51579. As of Q4 2014, SUFOSFAMIDE remains US FDA's Preferred Term for this commodity. Sufosfamide bears US NLM identifiers UMLS ID C0075494 and NCI Concept Code C73260. SMILES: CLCCN1P(=O)(OCCC1)NCCOS(=O)(=O)C.
Same parent
Under 51112500 · 28Activities that produce or sell this
KBLI · 8Inherited from family 51110000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.